Evidence map›Paper›PMID 29970990›Full record

ArticleFrontiers in cellular neuroscience2018

A Guide to Single-Cell Transcriptomics in Adult Rodent Brain: The Medium Spiny Neuron Transcriptome Revisited.

Hanson Ho, Matt De Both, Ashley Siniard, Sasha Sharma, James H Notwell, Michelle Wallace, Dino P Leone, Amy Nguyen, Eric Zhao, Hannah Lee and 5 more

Abstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Facilitating mGluR4 activity reverses the long-term deleterious consequences of chronic morphine exposure in male mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hanson HoCircuit Therapeutics, Inc., Menlo Park, CA, United States.
Matt De BothNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, United States.
Ashley SiniardNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, United States.
Sasha SharmaCircuit Therapeutics, Inc., Menlo Park, CA, United States.
James H NotwellCircuit Therapeutics, Inc., Menlo Park, CA, United States.
Michelle WallaceCircuit Therapeutics, Inc., Menlo Park, CA, United States.
Dino P LeoneCircuit Therapeutics, Inc., Menlo Park, CA, United States.
Amy NguyenCircuit Therapeutics, Inc., Menlo Park, CA, United States.
Eric ZhaoCircuit Therapeutics, Inc., Menlo Park, CA, United States.
Hannah LeeCircuit Therapeutics, Inc., Menlo Park, CA, United States.
Daniel ZwillingCircuit Therapeutics, Inc., Menlo Park, CA, United States.
Kimberly R ThompsonCircuit Therapeutics, Inc., Menlo Park, CA, United States.
Steven P BraithwaiteCircuit Therapeutics, Inc., Menlo Park, CA, United States.
Matthew HuentelmanNeurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, United States.
Thomas PortmannCircuit Therapeutics, Inc., Menlo Park, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in single-cell technologies are paving the way to a comprehensive understanding of the cellular complexity in the brain. Protocols for single-cell transcriptomics combine a variety of sophisticated methods for the purpose of isolating the heavily interconnected and heterogeneous neuronal cell types in a relatively intact and healthy state. The emphasis of single-cell transcriptome studies has thus far been on comparing library generation and sequencing techniques that enable measurement of the minute amounts of starting material from a single cell. However, in order for data to be comparable, standardized cell isolation techniques are essential. Here, we analyzed and simplified methods for the different steps critically involved in single-cell isolation from brain. These include enzymatic digestion, tissue trituration, improved methods for efficient fluorescence-activated cell sorting in samples containing high degree of debris from the neuropil, and finally, highly region-specific cellular labeling compatible with use of stereotaxic coordinates. The methods are exemplified using medium spiny neurons (MSN) from dorsomedial striatum, a cell type that is clinically relevant for disorders of the basal ganglia, including psychiatric and neurodegenerative diseases. We present single-cell RNA sequencing (scRNA-Seq) data from D1 and D2 dopamine receptor expressing MSN subtypes. We illustrate the need for single-cell resolution by comparing to available population-based gene expression data of striatal MSN subtypes. Our findings contribute toward standardizing important steps of single-cell isolation from adult brain tissue to increase comparability of data. Furthermore, our data redefine the transcriptome of MSNs at unprecedented resolution by confirming established marker genes, resolving inconsistencies from previous gene expression studies, and identifying novel subtype-specific marker genes in this important cell type.

Indexed as

basal gangliaCholinergic Receptor Muscarinic 4dopamine receptorsfluorescence-activated cell sortingsingle-cell RNA sequencingstriatal medium spiny neurons

Identifiers

PMID29970990
PMCPMC6018757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.